NHS
Web page
Sep 2026
For patients
Lists the main bowel cancer symptoms, several of which overlap with Crohn's: changes in poo, blood in poo that may look red or black, bleeding from the bottom, often feeling you need to poo, tummy pain, weight loss and tiredness from anaemia. Explains why these should be checked rather than assumed to be a flare.
Topics
Cancer risk and screening
Bleeding from the bottom
Symptoms
Jargon explained
bowel cancer
anaemia
tenesmus
Crohn's & Colitis UK
Guide
May 2025
For patients
Explains which people with Crohn's or Colitis have a raised risk of bowel and other gut cancers. Crohn's affecting the colon raises bowel cancer risk, starting about eight years after symptoms begin, and having PSC raises it further, while Crohn's that does not affect the colon does not. People at higher risk should be offered surveillance colonoscopy, usually every 1 to 3 years depending on risk. It also covers symptoms to watch for and ways to lower your risk.
Topics
Cancer risk and screening
Monitoring
Jargon explained
surveillance colonoscopy
primary sclerosing cholangitis
dysplasia
colorectal cancer
NICE
Guideline
Jun 2015
For professionals
NICE's guideline on which symptoms, including rectal bleeding, changes in bowel habit and iron deficiency anaemia, should lead to tests or urgent referral for possible cancer.
Topics
Cancer risk and screening
Bleeding from the bottom
Jargon explained
rectal bleeding
iron deficiency anaemia
NICE
Guideline
Sep 2022
For professionals
NICE's guideline on using regular colonoscopies to look for early signs of bowel cancer in adults with ulcerative colitis or Crohn's affecting the colon, and in people with polyps. Its aim is to find bowel cancer early in the people most at risk.
Topics
Monitoring
Cancer risk and screening
Jargon explained
colonoscopy
surveillance colonoscopy
polyp
adenoma
colorectal cancer
Gut (BMJ) via PubMed Central
Guideline
Apr 2025
For professionals
The 2025 UK guideline on regular colonoscopy checks for bowel cancer in adults with IBD affecting the colon, updating the 2010 version. It notes that people with IBD still have a higher bowel cancer risk than the general population and makes 73 statements on how a surveillance service should be run.
Topics
Monitoring
Cancer risk and screening
Jargon explained
surveillance colonoscopy
colorectal cancer
British Society of Gastroenterology
Guideline
2025
For professionals
The 2025 update of UK guidance on bowel cancer surveillance for people over 16 with IBD affecting the colon. It says people with IBD still have a higher risk of bowel cancer than the general population despite better treatment, and sets out who should and should not have surveillance, when to start and stop, and the importance of shared decision-making with patients.
Topics
Cancer risk and screening
Monitoring
Jargon explained
surveillance colonoscopy
dysplasia
colorectal cancer
NICE Clinical Knowledge Summaries
Guide
May 2024
For professionals
NICE's GP summary listing the complications of Crohn's: the effect on school, work and social life, narrowings, fistulas, disease around the bottom, perforation, heavy bleeding, anaemia, poor nutrition and slow growth in children, and a raised risk of bowel cancer when Crohn's affects the colon.
Topics
Complications
Cancer risk and screening
Jargon explained
stricture
fistula
perforation
malabsorption
NHS
Web page
Apr 2023
For patients
The NHS guide to blood from the bottom: what it can look like (blood on the paper, red streaks, pink water, bloody diarrhoea, very dark poo), and a clear ladder of when to see a GP, when to get an urgent appointment or use 111, and when to go to A&E or call 999. It groups likely causes by colour and other symptoms, from piles and anal fissures through IBD to bleeding higher up the gut, and notes that iron tablets and some foods can change the colour of poo.
Topics
Bleeding from the bottom
Symptoms
Urgent help
Jargon explained
rectal bleeding
haemorrhoids
anal fissure
anal fistula
angiodysplasia
anticoagulants
rectal examination
inflammatory bowel disease
European Crohn's and Colitis Organisation (J Crohns Colitis)
Guideline
Jul 2025
For professionals
A joint European guideline from gut doctors, radiologists, pathologists and bowel ultrasound experts on which tests to use to diagnose IBD, spot complications and keep track of it over time. It also covers testing in special situations such as pregnancy, after surgery and bowel cancer screening.
Topics
Diagnosis and tests
Monitoring
Cancer risk and screening
Jargon explained
intestinal ultrasound
MRI enterography
histology
surveillance colonoscopy
Alimentary Pharmacology & Therapeutics
Data
May 2020
Patients and professionals
Using UK GP records from 2000 to 2017, this study found Crohn's became more common, rising from about 220 to 400 per 100,000 people. It predicted about 1 in 90 people in the UK would have IBD by 2025. Colitis was linked to a higher risk of bowel cancer, and both conditions to a somewhat higher risk of death than people without IBD.
Topics
About Crohn's disease
Cancer risk and screening
Research
Jargon explained
epidemiology
prevalence
hazard ratio
all-cause mortality
Cochrane
Systematic review
Jan 2021
Patients and professionals
Looks at iron tablets and iron drips for anaemia caused by low iron in IBD. The reviewers found the evidence too weak to say for certain which works best, even though both are widely used and guidelines favour drips. They highlight this as an important gap.
Topics
Anaemia
Research
Jargon explained
iron deficiency anaemia
intravenous iron
ferric carboxymaltose
NICE
Guideline
Oct 2013
For professionals
NICE's recommendation that a faecal calprotectin poo test can be used to help doctors tell IBD apart from IBS. For adults with recent lower gut symptoms it applies when cancer is not suspected and proper quality checks and local pathways are in place; it is also recommended for children with suspected IBD who have been referred to a specialist. This guidance was first published as DG11 and NICE has since renumbered it HTG320 without changing it.
Topics
Diagnosis and tests
Jargon explained
faecal calprotectin
inflammatory bowel disease
irritable bowel syndrome